Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Phizer just bought arena PHarm---

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Dec 13, 2021 10:00am

701 Views

Post# 34224621

RE:Phizer just bought arena PHarm---

Pfizer has agreed to buy U.S. biotech company Arena Pharmaceuticals in a deal valued at about $6.7 billion. ... Under the agreement, Pfizer will acquire all the outstanding shares of Arena for $100 a share in an all-cash deal. That represents a 100.2% premium to Friday's closing price on Arena shares.

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand